Requirements for Additional Traceability Records for Certain Foods; Extension of Comment Period; Reopening of the Comment Period, 82393-82395 [2020-27829]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS
consumer perception studies, or
consumer complaints, that demonstrates
the extent of such practices. Provide any
evidence that demonstrates whether
such practices cause consumer injury,
and quantify or estimate that injury if
possible.
(10) Technological or Economic
Changes: What modifications, if any,
should be made to the Rule to account
for current or impending changes in
technology or economic conditions?
How would these modifications affect
the costs and benefits of the Rule for
consumers and businesses, particularly
small businesses?
(11) Conflicts With Other
Requirements: Does the Rule overlap or
conflict with other federal, state, or local
laws or regulations? If so, how? Provide
any evidence that supports your
position. With reference to the asserted
conflicts, should the Rule be modified?
If so, why, and how? If not, why not?
Are there any Rule changes necessary to
help state law enforcement agencies
combat deceptive practices in the
market for amplifiers utilized in home
entertainment products? Provide any
evidence concerning whether the Rule
has assisted in promoting national
consistency with respect to the
advertising of amplifiers utilized in
home entertainment products.
IV. Comment Submissions
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before February 16, 2021. Include
‘‘Amplifier Rule Review, 16 CFR part
432, Project No. P974222’’ on your
comment. Your comment, including
your name and your state, will be
placed on the public record of this
proceeding, including, to the extent
practicable, on the https://
www.regulations.gov website.
Because of the public health
emergency in response to the COVID–19
outbreak and the agency’s heightened
security screening, postal mail
addressed to the Commission will be
subject to delay. We strongly encourage
you to submit your comment online
through the https://www.regulations.gov
website. To ensure the Commission
considers your online comment, please
follow the instructions on the webbased form.
If you file your comment on paper,
write ‘‘Amplifier Rule Review, 16 CFR
part 432, Project No. P974222’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex A),
Washington, DC 20580, or deliver your
VerDate Sep<11>2014
19:58 Dec 17, 2020
Jkt 253001
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610,
Washington, DC 20024. If possible,
please submit your paper comment to
the Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible website,
https://www.regulations.gov, you are
solely responsible for making sure that
your comment does not include any
sensitive or confidential information. In
particular, your comment should not
include any sensitive personal
information such as your or anyone’s
Social Security number, date of birth,
driver’s license number or other state
identification number or foreign country
equivalent, passport number, financial
account number, or credit or debit card
number. You are also solely responsible
for making sure that your comment does
not include any sensitive health
information, such as medical records or
other individually identifiable health
information. In addition, your comment
should not include any ‘‘[t]rade secret or
any commercial or financial information
which . . . is privileged or
confidential’’—as provided in section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov—as legally
required by FTC Rule 4.9(b)—we cannot
redact or remove your comment, unless
you submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
Visit the FTC website to read this
request for comment and the news
release describing it. The FTC Act and
other laws that the Commission
administers permit the collection of
public comments to consider and use in
PO 00000
Frm 00003
Fmt 4702
Sfmt 4702
82393
this proceeding as appropriate. The
Commission will consider all timely
and responsive public comments that it
receives on or before February 16, 2021.
For information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2020–27569 Filed 12–17–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1
[Docket No. FDA–2014–N–0053]
RIN 0910–AI44
Requirements for Additional
Traceability Records for Certain
Foods; Extension of Comment Period;
Reopening of the Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Proposed rule; extension of
comment period; reopening of the
comment period.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is extending the comment period for
the proposed rule and reopening the
comment period for the information
collection related to the proposed rule
entitled ‘‘Requirements for Additional
Traceability Records for Certain Foods’’
that appeared in the Federal Register of
September 23, 2020. We are taking this
action in response to a request from
stakeholders to extend the comment
period to allow additional time for
interested persons to submit comments
on the proposed rule. We also are taking
this action to keep the comment period
for the information collection provisions
associated with the rule consistent with
the comment period for the proposed
rule.
SUMMARY:
FDA is extending the comment
period on the proposed rule published
September 23, 2020 (85 FR 59984).
Submit either electronic or written
comments on the proposed rule by
February 22, 2021. Submit comments on
information collection issues under the
Paperwork Reduction Act of 1995 (PRA)
by February 22, 2021.
ADDRESSES: You may submit comments
as follows. Please note that late,
DATES:
E:\FR\FM\18DEP1.SGM
18DEP1
82394
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Proposed Rules
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before February 22,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of February 22, 2021.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
To ensure that comments on the
information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. The OMB
control number for this information
collection is 0910–0560. Also include
the FDA docket number found in
brackets in the heading of this
document.
Electronic Submissions
khammond on DSKJM1Z7X2PROD with PROPOSALS
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
VerDate Sep<11>2014
19:58 Dec 17, 2020
Jkt 253001
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–N–0053 for ‘‘Requirements for
Additional Traceability Records for
Certain Foods.’’ Received comments,
those filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00004
Fmt 4702
Sfmt 4702
Regarding the proposed rule: Brian
Pendleton, Office of Policy, Food and
Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD
20993–0002, 301–796–4614,
Brian.Pendleton@fda.hhs.gov.
Regarding the information collection:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In the
Federal Register of September 23, 2020
(85 FR 59984), we published a proposed
rule entitled ‘‘Requirements for
Additional Traceability Records for
Certain Foods’’ with a 120-day comment
period on the provisions of the
proposed rule and a 60-day comment
period on the information collection
provisions that are subject to review by
the Office of Management and Budget
(OMB) under the Paperwork Reduction
Act (44 U.S.C. 3501–3521).
SUPPLEMENTARY INFORMATION:
FDA has received a request for a 60day extension of the comment period for
the provisions of the proposed rule and
an extension of the comment period for
the information collection provisions to
align with the end of the comment
period for the provisions of the
proposed rule. The request conveyed
concern that the current 120-day
comment period does not allow
stakeholders time to thoroughly analyze
the rule due to its complexity and
competing priorities. The request also
noted that stakeholders cannot provide
meaningful feedback on the information
collection burden of the proposed rule
without first having given the entire
proposed rule thorough consideration,
and therefore asked that the comment
period for the information collection
provisions be extended to align with the
comment period for the provisions of
the proposed rule. We have concluded
that it is reasonable to extend for 30
days the comment period for the
provisions of the proposed rule. The
Agency believes that this extension
allows adequate time for any interested
persons to submit comments on the
proposed rule. We also are extending
the comment period for the information
collection provisions to February 22,
2021, to align the comment period for
the information collection provisions
with the comment period for the
provisions of the proposed rule.
E:\FR\FM\18DEP1.SGM
18DEP1
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Proposed Rules
Dated: December 2, 2020.
Stephen M. Hahn,
Commissioner of Food and Drugs.
Dated: December 11, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2020–27829 Filed 12–17–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 152
[Docket No. FDA–2020–N–1690]
RIN 0910–AI17
Frozen Cherry Pie; Proposed
Revocation of a Standard of Identity
and a Standard of Quality
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Proposed rule.
The Food and Drug
Administration (FDA or we) proposes to
revoke the standard of identity and the
standard of quality for frozen cherry pie.
This action, in part, responds to a
citizen petition submitted by the
American Bakers Association (ABA).
We tentatively conclude that these
standards are no longer necessary to
promote honesty and fair dealing in the
interest of consumers. We also
tentatively conclude that revoking the
standards of identity and quality for
frozen cherry pie would provide greater
flexibility in the product’s manufacture,
consistent with comparable,
nonstandardized foods available in the
marketplace.
DATES: Submit either electronic or
written comments on the proposed rule
by March 18, 2021.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before March 18,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of March 18, 2021. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
khammond on DSKJM1Z7X2PROD with PROPOSALS
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
VerDate Sep<11>2014
19:58 Dec 17, 2020
Jkt 253001
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–1690 for ‘‘Frozen Cherry Pie;
Proposed Revocation of a Standard of
Identity and a Standard of Quality.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
PO 00000
Frm 00005
Fmt 4702
Sfmt 4702
82395
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Andrea Krause, Center for Food Safety
and Applied Nutrition (HFS–820), Food
and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240–402–
3719.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Executive Summary
A. Purpose of the Proposed Rule
B. Summary of the Major Provisions of the
Proposed Rule
C. Legal Authority
D. Costs and Benefits
II. Background
III. ABA Citizen Petition and Grounds
IV. Description of the Proposed Rule
V. Preliminary Economic Analysis of Impacts
VI. Analysis of Environmental Impact
VII. Paperwork Reduction Act of 1995
VIII. Consultation and Coordination With
Indian Tribal Governments
IX. Federalism
X. Reference
I. Executive Summary
A. Purpose of the Proposed Rule
This proposed rule, if finalized,
would revoke the standards of identity
and quality for frozen cherry pie. This
action, in part, responds to a citizen
petition submitted by the American
E:\FR\FM\18DEP1.SGM
18DEP1
]]>Agencies
[Federal Register Volume 85, Number 244 (Friday, December 18, 2020)]
[Proposed Rules]
[Pages 82393-82395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27829]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1
[Docket No. FDA-2014-N-0053]
RIN 0910-AI44
Requirements for Additional Traceability Records for Certain
Foods; Extension of Comment Period; Reopening of the Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Proposed rule; extension of comment period; reopening of the
comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
extending the comment period for the proposed rule and reopening the
comment period for the information collection related to the proposed
rule entitled ``Requirements for Additional Traceability Records for
Certain Foods'' that appeared in the Federal Register of September 23,
2020. We are taking this action in response to a request from
stakeholders to extend the comment period to allow additional time for
interested persons to submit comments on the proposed rule. We also are
taking this action to keep the comment period for the information
collection provisions associated with the rule consistent with the
comment period for the proposed rule.
DATES: FDA is extending the comment period on the proposed rule
published September 23, 2020 (85 FR 59984). Submit either electronic or
written comments on the proposed rule by February 22, 2021. Submit
comments on information collection issues under the Paperwork Reduction
Act of 1995 (PRA) by February 22, 2021.
ADDRESSES: You may submit comments as follows. Please note that late,
[[Page 82394]]
untimely filed comments will not be considered. Electronic comments
must be submitted on or before February 22, 2021. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of February 22, 2021. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.
To ensure that comments on the information collection are received,
OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0560. Also include the FDA docket
number found in brackets in the heading of this document.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-N-0053 for ``Requirements for Additional Traceability Records
for Certain Foods.'' Received comments, those filed in a timely manner
(see ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT:
Regarding the proposed rule: Brian Pendleton, Office of Policy,
Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring,
MD 20993-0002, 301-796-4614, [email protected].
Regarding the information collection: Domini Bean, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733,
[email protected].
SUPPLEMENTARY INFORMATION: In the Federal Register of September 23,
2020 (85 FR 59984), we published a proposed rule entitled
``Requirements for Additional Traceability Records for Certain Foods''
with a 120-day comment period on the provisions of the proposed rule
and a 60-day comment period on the information collection provisions
that are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act (44 U.S.C. 3501-3521).
FDA has received a request for a 60-day extension of the comment
period for the provisions of the proposed rule and an extension of the
comment period for the information collection provisions to align with
the end of the comment period for the provisions of the proposed rule.
The request conveyed concern that the current 120-day comment period
does not allow stakeholders time to thoroughly analyze the rule due to
its complexity and competing priorities. The request also noted that
stakeholders cannot provide meaningful feedback on the information
collection burden of the proposed rule without first having given the
entire proposed rule thorough consideration, and therefore asked that
the comment period for the information collection provisions be
extended to align with the comment period for the provisions of the
proposed rule. We have concluded that it is reasonable to extend for 30
days the comment period for the provisions of the proposed rule. The
Agency believes that this extension allows adequate time for any
interested persons to submit comments on the proposed rule. We also are
extending the comment period for the information collection provisions
to February 22, 2021, to align the comment period for the information
collection provisions with the comment period for the provisions of the
proposed rule.
[[Page 82395]]
Dated: December 2, 2020.
Stephen M. Hahn,
Commissioner of Food and Drugs.
Dated: December 11, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2020-27829 Filed 12-17-20; 8:45 am]
BILLING CODE 4164-01-P
